- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hamilton acquires integration assets from Pontis
Hamilton Scientific, a developer of Internet-based medical applications, has purchased the assets of Pontis Medical, a developer of remote access solutions for the healthcare industry. Pontis created the eM-Net system (now called MedFreedom),
Hamilton Scientific, a developer of Internet-based medical applications, has purchased the assets of Pontis Medical, a developer of remote access solutions for the healthcare industry. Pontis created the eM-Net system (now called MedFreedom), which is designed to connect hospitals, imaging centers, and other healthcare facilities with affiliated physicians via the Internet. Hamilton intends to make MedFreedom the platform for communication and electronic transactions between physicians and the institutions they work with. Hamilton's products include myPatientCharts.com and Duet, which will be available to all physicians participating on the MedFreedom network. myPatientCharts is an XML- and Java-based application that allows the secure exchange of patient information over the Internet, while Duet is a messaging application.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
